Acne vulgaris. Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 12 to 30 years; GAGS score between 1 and 30; signature consent form. Exclusion criteria: previous consumption of oral acne controller medications, such as antibiotics, isotretinoin, oral contraceptive pills; administration of drugs that caused acne such as testosterone, progesterone, steroids, lithium, phenytoin, and isoniazid; patients with symptoms of endocrine disorders especially hyperandrogegism, including polycystic ovarian syndrome (oligomenorrhea, polycystic ovaries, hirsutism), Cushing syndrome (rapid weight gain, buffalo hump, moon face, excess sweating, purple or red striae on the body and hirsutism), CAH, androgen-secreting tumors, and acromegaly; severe skin problem; women who were pregnant or lactating.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of skin lesions. Timepoint: At baseline, 30 and 60 days after intervention. Method of measurement: Global Acne Grading System (GAGS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in lesions count (total, inflammatory, non-inflammatory and regional). Timepoint: At baseline, 30 and 60 days after intervention. Method of measurement: visual counting. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz university of medical science